What Happened?
Seattle, WA-based Icosavax Appointed Thomas Russo as Chief Financial Officer
About the Company
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. The company was founded on breakthrough computationally-designed virus like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington. Icosavax is located in Seattle.
About the Person
Thomas Russo is Chief Financial Officer at Icosavax. Previously, Thomas held various senior HR leadership roles in the industry.
Info Source
News
Short Profile